COVID-19 UPDATE

Contact

BDSI remains committed to the chronic pain community during the COVID-19 pandemic. For more
information on access to our products, please call our customer service line at 1-800-469-0261.

Events & Presentations

Past Events

BDSI Second Quarter 2021 Financial Results Call and Webcast

Aug 4, 2021 at 8:30 AM EDT

Listen to webcast

Supporting Materials

View Presentation 1.5 MB

May Investor Presentation

May 11, 2021

Supporting Materials

View Presentation 1 MB

BDSI First Quarter 2021 Financial Results Call and Webcast

May 6, 2021 at 8:30 AM EDT

Listen to webcast

Supporting Materials

View Presentation 622.2 KB

BDSI Fourth Quarter 2020 Financial Results Call and Webcast

Mar 10, 2021 at 8:30 AM EST

Listen to webcast

Supporting Materials

View Presentation 751.1 KB

Piper Sandler 32nd Annual Healthcare Conference

Nov 23, 2020

Southwest IDEAS Investor Conference

Nov 18, 2020 at 8:00 AM EST

Listen to webcast

BDSI Third Quarter 2020 Financial Results Call and Webcast

Nov 5, 2020 at 8:30 AM EST

Listen to webcast

Supporting Materials

View Presentation 601.9 KB

Cantor Fitzgerald Global Healthcare Conference

Sep 17, 2020 at 11:20 AM EDT

Listen to webcast

H.C. Wainwright 22nd Annual Global Investor Conference

Sep 14, 2020 at 12:30 PM EDT

Listen to webcast

Recent BDSI News

BioDelivery Sciences Reports Second Quarter 2021 Results August 4, 2021

Total Company Net Revenue of $41.4 Million Driven by BELBUCA ® All-Time High TRx Market Share Strong Profitability with GAAP Net Income of $9.1 Million , or $0.09 per share, EBITDA Margin of 32%, and Non-GAAP Net Income of $12.5 Million , or $0.12 per Share, Drives Operating Cash Generation of $9.2 ...

BioDelivery Sciences Announces Agreement to Acquire U.S. and Canadian Rights to FDA-approved ELYXYB™ for the Acute Treatment of Migraine August 4, 2021

The only FDA-approved, ready-to-use oral solution for the acute treatment of migraine with or without aura in adults First step to building a growth platform in Neurology Patent protection until 2036 RALEIGH, N.C. , Aug. 04, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International , ...

BioDelivery Sciences to Report Second Quarter 2021 Financial Results on August 4, 2021 July 22, 2021

RALEIGH, N.C. , July 22, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that it will report its second quarter 2021 ...

More news

More events

Stay Connected

Stay up to date on the latest news

Get started now